Compare IDEXX Laboratories, Inc. (IDXX) vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF (QDTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? IDEXX Laboratories, Inc. trades at $560 (market cap $44.48B), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $40.04. The key difference: YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | QDTY | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $766.68 | $46.71 |
52-Week Low | $520.87 | $36.57 |
Enterprise Value | $45.38B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
QDTY trades at $39.53 with minimal daily movement (+0.15%). The stock demonstrates consistent dividend distributions with weekly payouts ranging from $0.22 to $0.32 per share throughout 2026. Technical indicators show stable price action while fundamental metrics remain undisclosed in available data. Recent corporate actions focus exclusively on dividend distributions with no significant business developments reported.
The outlook for QDTY appears income-focused given the regular dividend schedule, though fundamental analysis is limited by missing financial ratios. Key risks include dependency on dividend sustainability and potential market volatility. Investment appeal centers on yield generation rather than growth prospects, requiring careful monitoring of underlying financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF
QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.
Read more on QDTY →
